Tocilizumab for Acute Chest Syndrome
NCT05640271
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Sickle Cell Disease
Acute Chest Syndrome
Interventions
DRUG:
Tocilizumab
Sponsor
University of Chicago